| Typicality: | 0.527 |
| Saliency: | 0.269 |
| against other drugs | 8 | other |
| against a placebo | 8 | transitive-object |
| trial → compare → reboxetine | 16 |
| negative | neutral | positive |
| 0.146 | 0.511 | 0.343 |
| Raw frequency | 16 |
| Normalized frequency | 0.269 |
| Modifier score | 1.000 |
| Perplexity | 129.888 |